CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

Phase 3

Development Phase

5

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Oct '27
RHHBYPhase 2

Atezolizumab Phase 2 Est. Readout

Atezolizumab
Oct 2027~
CT.gov
00%
Q2 '27
RHHBYPhase 3

Atezolizumab Phase 3 Est. Readout

Atezolizumab
Q2 2027~Q
CT.gov
00%
Mar '27
RHHBYPhase 3

Atezolizumab Phase 3 Est. Readout

Atezolizumab
Mar 2027~
CT.gov
00%
Dec '26
RHHBYPhase 2

Atezolizumab Phase 2 Est. Readout

Atezolizumab
Dec 2026~
CT.gov
00%
Oct '26
RHHBYPhase 2

Atezolizumab Phase 2 Est. Readout

Atezolizumab
Oct 2026~
CT.gov
00%
Competitive Landscape
Drug Information

Target Indication

Triple-Negative Breast Cancer

Clinical Trial

NCT04148911

Last updated: 8/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.